3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Conditions
Small Cell Lung Carcinoma
7
Lung Neoplasms
3
Neoplasm Metastasis
2
Carcinoma, Non-Small-Cell Lung
2
Solid Tumors
1
Sarcoma
1
Platinum-Resistant Lung Small Cell Carcinoma
1
Neutropenia
1
Neuroendocrine Tumors
1
Mesothelioma, Malignant
1
Mesothelioma
1
Gastrointestinal Malignancies
1
Desmoplastic Small Round Cell Tumor
1
Carcinoma, Transitional Cell
1
Breast Neoplasms
1
Advanced Solid Tumors
1
Adenoma, Islet Cell
1
Interventions
Etoposide
5
Doxorubicin
5
Vincristine
4
Ifosfamide
4
Cyclophosphamide
4
Filgrastim
3
fludarabine phosphate
2
Thiotepa
2
Tacrolimus
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Melphalan
2
Injections
2
Cyclosporine
2
Carboplatin
2
thymoglobulin
1
temsirolimus
1
spartalizumab
1
pazopanib
1
pasireotide
1
exatecan
1
Topotecan
1
Temozolomide
1
Taxes
1
Surgical Procedures, Operative
1
Sunitinib
1
Stem Cell Transplantation
1
Sorafenib
1
Sirolimus
1
Radiotherapy, Intensity-Modulated
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Desmoplastic Small Round Cell Tumor
×
PM 01183
×
Clear all
NCT07328425
2026-04-03
ISG-TULIPS
Italian Sarcoma Group
Phase 2
Recruiting
20 enrolled